{
    "nctId": "NCT03939156",
    "briefTitle": "Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer",
    "officialTitle": "Evaluation of Endocrine Therapy and Patients Preferences in Early Breast Cancer - Patients' Preferences for Adjuvant Endocrine Therapy in Early Breast Cancer.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer, Endocrine Breast Diseases",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 450,
    "primaryOutcomeMeasure": "Percentage of risk reduction needed to consider endocrine therapy worthwhile",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women candidate to adjuvant hormonal therapy for breast cancer before the start of therapy\n* Women who are receiving hormonal therapy (within 1 year from beginning)\n* Women who are receiving hormonal therapy (who had receive at least 4 or 5 or 6 years of hormonal therapy)\n* Patients who underwent to radical surgery for breast cancer\n* Patients who have received neoadjuvant or adjuvant chemotherapy are also eligible\n* Hormonal receptors positive breast cancer (ER and or PgR \\>1%)\n* Sufficient literacy in Italian to complete the questionnaires.\n\nExclusion Criteria:\n\n* Patients who had received at least 1 year and no more than 3 years of hormonal therapy\n* Patients who are receiving hormonal therapy (who had receive 7 years or more of hormonal therapy)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}